Vascular Biogenics Ltd. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was USD 0.064 million compared to USD 0.188 million a year ago. Net loss was USD 9.43 million compared to USD 8.03 million a year ago. Basic loss per share from continuing operations was USD 0.12 compared to USD 0.12 a year ago.
For the six months, sales was USD 0.177 million compared to USD 0.373 million a year ago. Net loss was USD 19.86 million compared to USD 14.31 million a year ago. Basic loss per share from continuing operations was USD 0.26 compared to USD 0.24 a year ago.